Tumor-targeted delivery of a STING agonist improves cancer immunotherapy

The cGAS-STING pathway is essential for immune defense against microbial pathogens and malignant cells; as such, STING is an attractive target for cancer immunotherapy. However, systemic administration of STING agonists poses safety issues while intratumoral injection is limited by tumor accessibili...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, You-tong, Fang, Yan, Wei, Qi, Shi, Heping, Tan, Huiling, Deng, Yafang, Zeng, Zhiqun, Qiu, Jian, Chen, Chuo, Sun, Lijun, Chen, Zhijian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894229/
https://www.ncbi.nlm.nih.gov/pubmed/36442099
http://dx.doi.org/10.1073/pnas.2214278119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894229/
https://www.ncbi.nlm.nih.gov/pubmed/36442099
http://dx.doi.org/10.1073/pnas.2214278119

Ejemplares similares